Chris Page
Senior Healthcare Consultant
Indianapolis, IN, US
Publications
Read their latest work
Article
4 considerations for life sciences companies related to Medicare Advantage and standalone PDP Star Ratings
25 November 2025 - by Rachel Crum, Ben Diner, Chris Page
We offer guidance to life sciences companies on Medicare Advantage and Star Ratings for standalone prescription drug plans.
Video
Navigating the future: Market disruptions in life sciences
04 June 2025 - by Katherine M. Holcomb, Tyler Engel, Chris Page, Matthew Hayes
Explore the transformative impact of the Inflation Reduction Act and other government policies on the life sciences industry in 2025 and beyond.
Video
Life Sciences Insights with Chris Page
05 December 2024 - by Chris Page, Andrew L. Naugle
Learn how Milliman’s health equity research is helping patients, pharmaceutical manufacturers, and other life sciences stakeholders.
Article
FTC pharmacy benefit management transparency report: How might pharma evaluate transparency reform impacts to drug channel stakeholders?
04 September 2024 - by Chad Barker, Chris Page, Matt Berman
In the wake of the FTC’s recent transparency report on pharmacy benefit managers, we look at how reform might impact drug channel stakeholders.
Article
Increasing diversity in clinical trials
27 June 2024 - by Chris Page, Ellyn Russo, Jeremy Engdahl-Johnson
Milliman health researchers discuss strategies and benefits of making sure new medical treatments are tested in patients from a range of backgrounds.